<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02346110</url>
  </required_header>
  <id_info>
    <org_study_id>ProtokolSB1</org_study_id>
    <secondary_id>2014-004207-78</secondary_id>
    <nct_id>NCT02346110</nct_id>
  </id_info>
  <brief_title>Protracted Effect of the Ultrasound-guided Saphenous Block</brief_title>
  <acronym>PEUSB</acronym>
  <official_title>Comparison of the Effect of a Single Shot Saphenous Block With Plain Bupivacaine vs. Protracted Bupivacaine Mixture as a Supplement to Continuous Sciatic Catheter After Major Ankle and Foot Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Aarhus</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Aarhus</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study focuses on optimizing the postoperative pain treatment after major foot and ankle
      surgery by prolonging the duration of the ultrasound-guided saphenous block. The currently
      used single shot saphenous block only covers half of the pain intensive period from the
      saphenous territory, which results in a sharp, break-through pain requiring opioids. The
      hypothesis is that this protracted mixture will keep the patients free of pain without the
      use of opioids for the entire pain intensive period and thus increase rehabilitation and
      patients' satisfaction.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Half of the patients will receive a single shot saphenous block with 10 mL
      bupivacaine-adrenalin and 1 mL of sodium chloride solution, while the other half will receive
      10 mL of bupivacaine-adrenalin and 1 mL of dexamethasone.

      The block is strictly a sensory block because it is a selective, sub-sartorial saphenous
      block at mid-thigh level without any anesthetic effect on the femoral nerve.

      The adjuvant dexamethasone has increasingly become a subject of interest regarding a
      protracted effect, which has been shown in several studies. However, the precise mechanism of
      action remains speculative, and the results are contradictory regarding the discussion
      whether the effect is systemic or local. The effect may stem from decreased nociceptive
      C-fibre activity via a direct action on glucocorticoid receptors and inhibitory potassium
      channels. Another suggestion is a vasoconstrictive effect, which reduces the systemic uptake
      of local anaesthetics or a systemic anti-inflammatory effect.

      Prolonging the effect of the single shot saphenous block by adding dexamethasone will reduce
      the need for opioids, which will reduce the risk of adverse effects like nausea, vomiting and
      respiratory depression. Furthermore, newer studies show that inadequate pain alleviation in
      the early postoperative period is a risk factor in developing chronic persistent pain.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 2015</start_date>
  <completion_date type="Actual">February 2016</completion_date>
  <primary_completion_date type="Actual">December 2015</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Duration of the saphenous nerve block</measure>
    <time_frame>48 hours</time_frame>
    <description>The duration is registered as the time until the first dose of morphine is taken, and when the pain score is above 3 and located to the frontal or medial side of the ankle. Morphine is administered intravenously by a patient controlled pump (PCA - Patient Controlled Analgesia)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Cumulated opioid consumption</measure>
    <time_frame>48 hours</time_frame>
    <description>Registered by the PCA pump</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain score</measure>
    <time_frame>Arrival at the Perioperative Section which will be within 30 minutes after surgery. Departure from the Perioperative Section which is expected to be on average 2 hours after surgery. 6, 12, 24, 30, 36, 42 and 48 hours after surgery</time_frame>
    <description>NRS (numeric rating scale)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain localization</measure>
    <time_frame>Arrival at the Perioperative Section which will be within 30 minutes after surgery. Departure from the Perioperative Section which is expected to be on average 2 hours after surgery. 6, 12, 24, 30, 36, 42 and 48 hours after surgery</time_frame>
    <description>Lateral or medial side of the ankle</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Test of sensory block</measure>
    <time_frame>Arrival at the Perioperative Section which will be within 30 minutes after surgery. Departure from the Perioperative Section which is expected to be on average 2 hours after surgery. 6, 12, 24, 30, 36, 42 and 48 hours after surgery</time_frame>
    <description>The sensory block of the peroneal nerve is tested on the dorsal side of the toes and the tibial nerve on the plantar side of the toes.
The ankle and lower leg is covered in cast, and therefore the saphenous nerve is tested around the tibial tuberosity because this area is innervated by the infra-patellar nerve, which is a branch of the saphenous nerve</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">40</enrollment>
  <condition>Arthrosis, Unspecified, Ankle and Foot</condition>
  <arm_group>
    <arm_group_label>Bupivacaine-adrenalin + sodium chloride</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Single shot saphenous block:
10 mL of 5 mg/mL bupivacaine with 5 μg/mL adrenalin = 50 mg bupivacain and 50 μg adrenalin
1 mL sodium chloride solution</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Bupivacaine-adrenaline + Dexamethasone</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Single shot saphenous block:
10 mL of 5 mg/mL bupivacaine with 5 μg/mL adrenalin = 50 mg bupivacain and 50 μg adrenalin
1 mL of 4 mg/mL dexamethasone = 4 mg dexamethasone</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Bupivacaine-adrenaline</intervention_name>
    <description>50 mg bupivacaine and 50 μg adrenalin</description>
    <arm_group_label>Bupivacaine-adrenalin + sodium chloride</arm_group_label>
    <arm_group_label>Bupivacaine-adrenaline + Dexamethasone</arm_group_label>
    <other_name>Marcain-adrenalin</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexamethasone</intervention_name>
    <description>4 mg</description>
    <arm_group_label>Bupivacaine-adrenaline + Dexamethasone</arm_group_label>
    <other_name>Dexagalen</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Sodium chloride</intervention_name>
    <description>1 mL of sodium chloride solution as placebo</description>
    <arm_group_label>Bupivacaine-adrenalin + sodium chloride</arm_group_label>
    <other_name>NaCL</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Elective ankle or hind foot surgery either: (1) total ankle arthroplasty, (2) ankle
             arthrodesis or (3) subtalar arthrodesis

          -  Age ≥ 18

          -  American Society of Anaesthesiology Classification I-III

          -  Informed consent both orally and in writing after the patient has fully understood the
             protocol and its limitations.

        Exclusion Criteria:

          -  Communication problems or dementia

          -  Allergies to any medical product used in the study

          -  Neuropathy of the sciatic or femoral nerve prior to the operation

          -  Morbus Charcot-Marie-Tooth disease, diabetic neuropathy, peripheral vascular disease

          -  BMI &gt; 35

          -  Pregnancy

          -  Daily use of opioids

          -  Coagulation disorders

          -  Infection at the site of injection or systemic infection
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Thomas Fichtner Bendtsen, MD, phD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Anesthesiology, Aarhus University Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of Anesthesiology, Aarhus University Hospital</name>
      <address>
        <city>Aarhus</city>
        <state>Midtjylland</state>
        <zip>8000</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <reference>
    <citation>Clendenen SR, Whalen JL. Saphenous nerve innervation of the medial ankle. Local Reg Anesth. 2013 Mar 6;6:13-6. doi: 10.2147/LRA.S42603. Print 2013.</citation>
    <PMID>23630434</PMID>
  </reference>
  <reference>
    <citation>Joshi GP, Ogunnaike BO. Consequences of inadequate postoperative pain relief and chronic persistent postoperative pain. Anesthesiol Clin North America. 2005 Mar;23(1):21-36. Review.</citation>
    <PMID>15763409</PMID>
  </reference>
  <reference>
    <citation>Blumenthal S, Borgeat A, Neudörfer C, Bertolini R, Espinosa N, Aguirre J. Additional femoral catheter in combination with popliteal catheter for analgesia after major ankle surgery. Br J Anaesth. 2011 Mar;106(3):387-93. doi: 10.1093/bja/aeq365. Epub 2010 Dec 17.</citation>
    <PMID>21169609</PMID>
  </reference>
  <reference>
    <citation>Cepeda MS, Farrar JT, Baumgarten M, Boston R, Carr DB, Strom BL. Side effects of opioids during short-term administration: effect of age, gender, and race. Clin Pharmacol Ther. 2003 Aug;74(2):102-12.</citation>
    <PMID>12891220</PMID>
  </reference>
  <reference>
    <citation>White PF, Issioui T, Skrivanek GD, Early JS, Wakefield C. The use of a continuous popliteal sciatic nerve block after surgery involving the foot and ankle: does it improve the quality of recovery? Anesth Analg. 2003 Nov;97(5):1303-9. Erratum in: Anesth Analg. 2003 Dec;97(6):1557.</citation>
    <PMID>14570643</PMID>
  </reference>
  <reference>
    <citation>Richman JM, Liu SS, Courpas G, Wong R, Rowlingson AJ, McGready J, Cohen SR, Wu CL. Does continuous peripheral nerve block provide superior pain control to opioids? A meta-analysis. Anesth Analg. 2006 Jan;102(1):248-57.</citation>
    <PMID>16368838</PMID>
  </reference>
  <reference>
    <citation>Ya Deau JT, Wukovits BU, LaSala VR, Jules-Elysée KM, Paroli L, Kahn RL, Levine DS, Lipnitsky JY. Similar analgesic effect after popliteal fossa nerve blockade with 0.375% and 0.75% bupivacaine. HSS J. 2007 Sep;3(2):173-6. doi: 10.1007/s11420-007-9052-5.</citation>
    <PMID>18751790</PMID>
  </reference>
  <reference>
    <citation>Borgeat A, Blumenthal S, Lambert M, Theodorou P, Vienne P. The feasibility and complications of the continuous popliteal nerve block: a 1001-case survey. Anesth Analg. 2006 Jul;103(1):229-33, table of contents.</citation>
    <PMID>16790658</PMID>
  </reference>
  <reference>
    <citation>Jæger P, Zaric D, Fomsgaard JS, Hilsted KL, Bjerregaard J, Gyrn J, Mathiesen O, Larsen TK, Dahl JB. Adductor canal block versus femoral nerve block for analgesia after total knee arthroplasty: a randomized, double-blind study. Reg Anesth Pain Med. 2013 Nov-Dec;38(6):526-32. doi: 10.1097/AAP.0000000000000015.</citation>
    <PMID>24121608</PMID>
  </reference>
  <reference>
    <citation>Kwofie MK, Shastri UD, Gadsden JC, Sinha SK, Abrams JH, Xu D, Salviz EA. The effects of ultrasound-guided adductor canal block versus femoral nerve block on quadriceps strength and fall risk: a blinded, randomized trial of volunteers. Reg Anesth Pain Med. 2013 Jul-Aug;38(4):321-5. doi: 10.1097/AAP.0b013e318295df80.</citation>
    <PMID>23788068</PMID>
  </reference>
  <reference>
    <citation>Jaeger P, Nielsen ZJ, Henningsen MH, Hilsted KL, Mathiesen O, Dahl JB. Adductor canal block versus femoral nerve block and quadriceps strength: a randomized, double-blind, placebo-controlled, crossover study in healthy volunteers. Anesthesiology. 2013 Feb;118(2):409-15. doi: 10.1097/ALN.0b013e318279fa0b.</citation>
    <PMID>23241723</PMID>
  </reference>
  <reference>
    <citation>Bendtsen TF, Moriggl B, Chan V, Pedersen EM, Børglum J. Defining adductor canal block. Reg Anesth Pain Med. 2014 May-Jun;39(3):253-4. doi: 10.1097/AAP.0000000000000052.</citation>
    <PMID>24747312</PMID>
  </reference>
  <reference>
    <citation>Chen J, Lesser J, Hadzic A, Resta-Flarer F. The importance of the proximal saphenous nerve block for foot and ankle surgery. Reg Anesth Pain Med. 2013 Jul-Aug;38(4):372. doi: 10.1097/AAP.0b013e318295596a.</citation>
    <PMID>23788076</PMID>
  </reference>
  <reference>
    <citation>Förster JG, Rosenberg PH. Clinically useful adjuvants in regional anaesthesia. Curr Opin Anaesthesiol. 2003 Oct;16(5):477-86.</citation>
    <PMID>17021500</PMID>
  </reference>
  <reference>
    <citation>Choi S, Rodseth R, McCartney CJ. Effects of dexamethasone as a local anaesthetic adjuvant for brachial plexus block: a systematic review and meta-analysis of randomized trials. Br J Anaesth. 2014 Mar;112(3):427-39. doi: 10.1093/bja/aet417. Epub 2014 Jan 10. Review.</citation>
    <PMID>24413428</PMID>
  </reference>
  <reference>
    <citation>Movafegh A, Razazian M, Hajimaohamadi F, Meysamie A. Dexamethasone added to lidocaine prolongs axillary brachial plexus blockade. Anesth Analg. 2006 Jan;102(1):263-7.</citation>
    <PMID>16368840</PMID>
  </reference>
  <reference>
    <citation>Albrecht E, Kern C, Kirkham KR. A systematic review and meta-analysis of perineural dexamethasone for peripheral nerve blocks. Anaesthesia. 2015 Jan;70(1):71-83. doi: 10.1111/anae.12823. Epub 2014 Aug 14. Review.</citation>
    <PMID>25123271</PMID>
  </reference>
  <reference>
    <citation>Desmet M, Braems H, Reynvoet M, Plasschaert S, Van Cauwelaert J, Pottel H, Carlier S, Missant C, Van de Velde M. I.V. and perineural dexamethasone are equivalent in increasing the analgesic duration of a single-shot interscalene block with ropivacaine for shoulder surgery: a prospective, randomized, placebo-controlled study. Br J Anaesth. 2013 Sep;111(3):445-52. doi: 10.1093/bja/aet109. Epub 2013 Apr 15.</citation>
    <PMID>23587875</PMID>
  </reference>
  <reference>
    <citation>Kawanishi R, Yamamoto K, Tobetto Y, Nomura K, Kato M, Go R, Tsutsumi YM, Tanaka K, Takeda Y. Perineural but not systemic low-dose dexamethasone prolongs the duration of interscalene block with ropivacaine: a prospective randomized trial. Local Reg Anesth. 2014 Apr 5;7:5-9. doi: 10.2147/LRA.S59158. eCollection 2014.</citation>
    <PMID>24817819</PMID>
  </reference>
  <reference>
    <citation>Cummings KC 3rd, Napierkowski DE, Parra-Sanchez I, Kurz A, Dalton JE, Brems JJ, Sessler DI. Effect of dexamethasone on the duration of interscalene nerve blocks with ropivacaine or bupivacaine. Br J Anaesth. 2011 Sep;107(3):446-53. doi: 10.1093/bja/aer159. Epub 2011 Jun 14.</citation>
    <PMID>21676892</PMID>
  </reference>
  <reference>
    <citation>Vieira PA, Pulai I, Tsao GC, Manikantan P, Keller B, Connelly NR. Dexamethasone with bupivacaine increases duration of analgesia in ultrasound-guided interscalene brachial plexus blockade. Eur J Anaesthesiol. 2010 Mar;27(3):285-8. doi: 10.1097/EJA.0b013e3283350c38.</citation>
    <PMID>20009936</PMID>
  </reference>
  <reference>
    <citation>Rahangdale R, Kendall MC, McCarthy RJ, Tureanu L, Doty R Jr, Weingart A, De Oliveira GS Jr. The effects of perineural versus intravenous dexamethasone on sciatic nerve blockade outcomes: a randomized, double-blind, placebo-controlled study. Anesth Analg. 2014 May;118(5):1113-9. doi: 10.1213/ANE.0000000000000137.</citation>
    <PMID>24686045</PMID>
  </reference>
  <reference>
    <citation>Shrestha BR, Maharjan SK, Tabedar S. Supraclavicular brachial plexus block with and without dexamethasone - a comparative study. Kathmandu Univ Med J (KUMJ). 2003 Jul-Sep;1(3):158-60.</citation>
    <PMID>16388222</PMID>
  </reference>
  <reference>
    <citation>Parrington SJ, O'Donnell D, Chan VW, Brown-Shreves D, Subramanyam R, Qu M, Brull R. Dexamethasone added to mepivacaine prolongs the duration of analgesia after supraclavicular brachial plexus blockade. Reg Anesth Pain Med. 2010 Sep-Oct;35(5):422-6. doi: 10.1097/AAP.0b013e3181e85eb9.</citation>
    <PMID>20814282</PMID>
  </reference>
  <reference>
    <citation>Tandoc MN, Fan L, Kolesnikov S, Kruglov A, Nader ND. Adjuvant dexamethasone with bupivacaine prolongs the duration of interscalene block: a prospective randomized trial. J Anesth. 2011 Oct;25(5):704-9. doi: 10.1007/s00540-011-1180-x. Epub 2011 Jun 17.</citation>
    <PMID>21681533</PMID>
  </reference>
  <reference>
    <citation>Persec J, Persec Z, Kopljar M, Zupcic M, Sakic L, Zrinjscak IK, Marinic DK. Low-dose dexamethasone with levobupivacaine improves analgesia after supraclavicular brachial plexus blockade. Int Orthop. 2014 Jan;38(1):101-5. doi: 10.1007/s00264-013-2094-z. Epub 2013 Sep 6.</citation>
    <PMID>24173676</PMID>
  </reference>
  <reference>
    <citation>Kim YJ, Lee GY, Kim DY, Kim CH, Baik HJ, Heo S. Dexamathasone added to levobupivacaine improves postoperative analgesia in ultrasound guided interscalene brachial plexus blockade for arthroscopic shoulder surgery. Korean J Anesthesiol. 2012 Feb;62(2):130-4. doi: 10.4097/kjae.2012.62.2.130. Epub 2012 Feb 20.</citation>
    <PMID>22379567</PMID>
  </reference>
  <reference>
    <citation>Barrington MJ, Watts SA, Gledhill SR, Thomas RD, Said SA, Snyder GL, Tay VS, Jamrozik K. Preliminary results of the Australasian Regional Anaesthesia Collaboration: a prospective audit of more than 7000 peripheral nerve and plexus blocks for neurologic and other complications. Reg Anesth Pain Med. 2009 Nov-Dec;34(6):534-41.</citation>
    <PMID>19916206</PMID>
  </reference>
  <reference>
    <citation>Barrington MJ, Kluger R. Ultrasound guidance reduces the risk of local anesthetic systemic toxicity following peripheral nerve blockade. Reg Anesth Pain Med. 2013 Jul-Aug;38(4):289-99. doi: 10.1097/AAP.0b013e318292669b.</citation>
    <PMID>23788067</PMID>
  </reference>
  <reference>
    <citation>Compère V, Rey N, Baert O, Ouennich A, Fourdrinier V, Roussignol X, Beccari R, Dureuil B. Major complications after 400 continuous popliteal sciatic nerve blocks for post-operative analgesia. Acta Anaesthesiol Scand. 2009 Mar;53(3):339-45. doi: 10.1111/j.1399-6576.2008.01849.x.</citation>
    <PMID>19243320</PMID>
  </reference>
  <verification_date>October 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 13, 2015</study_first_submitted>
  <study_first_submitted_qc>January 19, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 26, 2015</study_first_posted>
  <last_update_submitted>February 11, 2016</last_update_submitted>
  <last_update_submitted_qc>February 11, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 12, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Joint Diseases</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dexamethasone acetate</mesh_term>
    <mesh_term>Dexamethasone</mesh_term>
    <mesh_term>Epinephrine</mesh_term>
    <mesh_term>Racepinephrine</mesh_term>
    <mesh_term>Epinephryl borate</mesh_term>
    <mesh_term>Bupivacaine</mesh_term>
    <mesh_term>BB 1101</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

